The Latin America, Middle East and Africa Anticoagulant Reversal Drugs Market would witness market growth of 14.3% CAGR during the forecast period (2021-2027).
The burden of cardiac arrhythmias has increased in Africa. Atrial fibrillation (AF) is the common type of arrhythmia and it is responsible for significant morbidity and mortality. Until recently, there were limited available treatment options with the support treatment of vitamin K antagonists (VKAs). The introduction of new anticoagulants has brought new hope to arrhythmia patients.
The risk factors, complications, and management of atrial fibrillation (AF) in sub-Saharan Africa need to be managed. The use of anticoagulation for the prevention of stroke is one of the therapeutic strategies. AF is sometimes associated with excessive bleeding in severe conditions and it requires the anticoagulent reversal drug. Thus, the demand for anticoagulation reversal drugs has increased in the sub-African region.
The geriatric population is directly proportional with the rising cases of blood-related disorders that require anticoagulation, thus boosting the demand for anticoagulants. In the past few years, clinicians have been supported by the increased availability of reversal agents. The advent and active research in developing targeted therapies such as idarucizumab have offered better treatment management for anticoagulant-associated bleeding and other periprocedural reversal.
Current trials evaluating aripazine and andexanet alfa will continue to widen the available regimen of effective agent-specific therapy. The reversal of a patient’s anticoagulation status solely depends on the health condition of the patient. The benefits of anticoagulant reversal drugs against the risks of thrombosis require a good understanding of anticoagulant intake by the patients and their respective antidotes.
The Hospital Pharmacy market dominated the UAE Anticoagulant Reversal Drugs Market by Distribution Channel in 2020, thereby, achieving a market value of $11.2 million by 2027. The Retail Pharmacy market is exhibiting a CAGR of 13.5% during (2021-2027). Additionally, The Online Pharmacy market is expected to witness highest CAGR of 15.4% during (2021-2027).
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on Product Type, the market is segmented into Idarucizumab, Andexanet Alfa, Prothrombin Complex Concentrates, Phytonadione, Protamine and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Anticoagulant Reversal Drugs Market is Predict to reach $1.6 Billion by 2027, at a CAGR of 13.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, CSL Limited, Bausch Health Companies, Inc., Octapharma AG, Pfizer, Inc., Fresenius SE & Co. KGaA, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), Dr. Reddy’s Laboratories Ltd., AMAG Pharmaceuticals, Inc. (Covis Pharma), and Alps Pharmaceutical Ind. Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Product Type
- Idarucizumab
- Andexanet Alfa
- Prothrombin Complex Concentrates
- Phytonadione
- Protamine
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Boehringer Ingelheim International GmbH
- CSL Limited
- Bausch Health Companies, Inc.
- Octapharma AG
- Pfizer, Inc.
- Fresenius SE & Co. KGaA
- Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
- Dr. Reddy’s Laboratories Ltd.
- AMAG Pharmaceuticals, Inc. (Covis Pharma)
- Alps Pharmaceutical Ind. Co., Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Anticoagulant Reversal Drugs Market, by Distribution Channel
1.4.2 LAMEA Anticoagulant Reversal Drugs Market, by Product Type
1.4.3 LAMEA Anticoagulant Reversal Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition:
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Opportunities:
Chapter 3. LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel
3.1 LAMEA Hospital Pharmacy Market by Country
3.2 LAMEA Retail Pharmacy Market by Country
3.3 LAMEA Online Pharmacy Market by Country
Chapter 4. LAMEA Anticoagulant Reversal Drugs Market by Product Type
4.1 LAMEA Idarucizumab Market by Country
4.2 LAMEA Andexanet Alfa Market by Country
4.3 LAMEA Prothrombin Complex Concentrates Market by Country
4.4 LAMEA Phytonadione Market by Country
4.5 LAMEA Other Product Type Market by Country
Chapter 5. LAMEA Anticoagulant Reversal Drugs Market by Country
5.1 Brazil Anticoagulant Reversal Drugs Market
5.1.1 Brazil Anticoagulant Reversal Drugs Market by Distribution Channel
5.1.2 Brazil Anticoagulant Reversal Drugs Market by Product Type
5.2 Argentina Anticoagulant Reversal Drugs Market
5.2.1 Argentina Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.2 Argentina Anticoagulant Reversal Drugs Market by Product Type
5.3 UAE Anticoagulant Reversal Drugs Market
5.3.1 UAE Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.2 UAE Anticoagulant Reversal Drugs Market by Product Type
5.4 Saudi Arabia Anticoagulant Reversal Drugs Market
5.4.1 Saudi Arabia Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.2 Saudi Arabia Anticoagulant Reversal Drugs Market by Product Type
5.5 South Africa Anticoagulant Reversal Drugs Market
5.5.1 South Africa Anticoagulant Reversal Drugs Market by Distribution Channel
5.5.2 South Africa Anticoagulant Reversal Drugs Market by Product Type
5.6 Nigeria Anticoagulant Reversal Drugs Market
5.6.1 Nigeria Anticoagulant Reversal Drugs Market by Distribution Channel
5.6.2 Nigeria Anticoagulant Reversal Drugs Market by Product Type
5.7 Rest of LAMEA Anticoagulant Reversal Drugs Market
5.7.1 Rest of LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel
5.7.2 Rest of LAMEA Anticoagulant Reversal Drugs Market by Product Type
Chapter 6. Company Profiles
6.1 Boehringer Ingelheim International GmbH
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional & Segmental Analysis
6.1.4 Research & Development Expenses
6.2 CSL Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Bausch Health Companies, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Octapharma AG
6.4.1 Company Overview
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.6 Fresenius SE & Co. KGaA
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Approvals:
6.8 Dr. Reddy’s Laboratories Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 AMAG Pharmaceuticals, Inc. (Covis Pharma)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Research & Development Expenses
6.9.4 Recent strategies and developments:
6.9.4.1 Partnerships, Collaborations, and Agreements:
6.9.4.2 Acquisition and Mergers:
6.10. Alps Pharmaceutical Ind. Co., Ltd.
6.10.1 Company Overview
TABLE 1 LAMEA Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 3 LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 4 LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 5 LAMEA Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 6 LAMEA Hospital Pharmacy Market by Country, 2021-2027, USD Million
TABLE 7 LAMEA Retail Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 8 LAMEA Retail Pharmacy Market by Country, 2021-2027, USD Million
TABLE 9 LAMEA Online Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 10 LAMEA Online Pharmacy Market by Country, 2021-2027, USD Million
TABLE 11 LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 12 LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 13 LAMEA Idarucizumab Market by Country, 2017 - 2020, USD Million
TABLE 14 LAMEA Idarucizumab Market by Country, 2021-2027, USD Million
TABLE 15 LAMEA Andexanet Alfa Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA Andexanet Alfa Market by Country, 2021-2027, USD Million
TABLE 17 LAMEA Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
TABLE 18 LAMEA Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
TABLE 19 LAMEA Phytonadione Market by Country, 2017 - 2020, USD Million
TABLE 20 LAMEA Phytonadione Market by Country, 2021-2027, USD Million
TABLE 21 LAMEA Other Product Type Market by Country, 2017 - 2020, USD Million
TABLE 22 LAMEA Other Product Type Market by Country, 2021-2027, USD Million
TABLE 23 LAMEA Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
TABLE 24 LAMEA Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
TABLE 25 Brazil Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 26 Brazil Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 27 Brazil Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 28 Brazil Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 29 Brazil Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 30 Brazil Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 31 Argentina Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 32 Argentina Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 33 Argentina Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 34 Argentina Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 35 Argentina Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 36 Argentina Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 37 UAE Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 38 UAE Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 39 UAE Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 40 UAE Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 41 UAE Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 42 UAE Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 43 Saudi Arabia Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 44 Saudi Arabia Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 45 Saudi Arabia Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 46 Saudi Arabia Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 47 Saudi Arabia Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 48 Saudi Arabia Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 49 South Africa Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 50 South Africa Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 51 South Africa Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 52 South Africa Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 53 South Africa Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 54 South Africa Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 55 Nigeria Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 56 Nigeria Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 57 Nigeria Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 58 Nigeria Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 59 Nigeria Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 60 Nigeria Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 61 Rest of LAMEA Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 62 Rest of LAMEA Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 63 Rest of LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 64 Rest of LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 65 Rest of LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 66 Rest of LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 67 Key Information – Boehringer Ingelheim International GmbH
TABLE 68 key Information – CSL Limited
TABLE 69 key information – Bausch Health Companies, Inc.
TABLE 70 Key Information – Octapharma AG
TABLE 71 Key Information – Pfizer, Inc.
TABLE 72 key information – Fresenius SE & Co. KGaA
TABLE 73 key information – Alexion Pharmaceuticals, Inc.
TABLE 74 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 75 key information – AMAG Pharmaceuticals, Inc.
TABLE 76 key information – Alps Pharmaceutical Ind. Co., Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: AMAG Pharmaceuticals, Inc.